Anti-CD47 antibodies can induce M1-like TAM development in tumor tissue and decrease tumor growth in a mouse model of non-small cell lung cancer (126, 127), and CD47 inhibition can switch TAM from a pro-tumor morphology to an anti-tumor phenotype in glioblastoma (128). The gene discussed is CD47; the disease is glioblastoma.